Covid-19 roundup: HHS official Giroir takes on role of testing czar — cue new controversy; Wuhan lab vehemently denies triggering the pandemic
Brett Giroir, once in the running to take on the mantle of FDA commissioner following the popular Scott Gottlieb’s abrupt departure, is President Trump’s pick to oversee coronavirus testing efforts, as shortfalls continue to bedevil the response to the pandemic. And it didn’t take long before his entry into the coronavirus spotlight spurred a controversy over his background.
His experience working on vaccine development projects at Texas A&M University helped prepare him for this historic moment, Giroir said in a Washington Post report. But in 2015, the Post notes, he was given half an hour to resign or be fired from the job at A&M after an annual performance revealed he was more interested in promoting himself than the health science center where he was employed.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 84,800+ biopharma pros reading Endpoints daily — and it's free.